MedTrace Logo

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

NCT02655029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2285

Last updated 2017-03-24

No results posted yet for this study

Summary

The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.

Conditions

  • Adherence to Medication Regime
  • Hypertensive Disease

Interventions

DRUG

Perindopril/Indapamide/Amlodipine fixed dose combination

Dose selection is based on investigators management.

Sponsors & Collaborators

  • Servier Hellas Pharmaceuticals Ltd.

    lead INDUSTRY

Principal Investigators

  • Konstantinos Tsioufis, Professor · Ippokrateion General Hospital of Athens

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-25
Primary Completion
2016-12-31
Completion
2016-12-21

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02655029 on ClinicalTrials.gov